News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Daiichi Sankyo, Inc. (4568.t) Pledges Bold Action On Ranbaxy Laboratories (RANBAXY.BO) Production Problems


1/31/2014 7:14:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Japan's Daiichi Sankyo Co Ltd said it would step up support of Indian drugmaking arm Ranbaxy Laboratories Ltd and send personnel to help resolve problems at a factory that U.S. regulators have banned from supplying pharmaceutical ingredients. "We have already put a lot of effort into our support but that has not been enough," Manabu Sakai, senior executive officer at Daiichi Sankyo, told an earnings briefing on Friday. "We want to go back and prepare a more aggressive, more drastic response."

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES